透過您的圖書館登入
IP:3.133.137.169

並列摘要


Introduction: Rhabdomyolysis is a potentially life-threatening condition caused by muscle necrosis and extravasation of intracellular muscle contents into the blood circulation. An elevation in serum creatine kinease is most confirmatory laboratory test. Erythromycin is an inhibitor of the CYP_3A_4 enzyme system which is responsible for the metabolism of several drugs, particularly some statins. Although rhabdomyolysis asssociated with macrolid-statin interaction has been previously described, we report the first case of erythromycin-induced rhabdomyolysis. Case Report: In our case, a 38-year-old male admitted with pneumonia developed rhabdomyolysis associated with erythromycin administration. Conclusion: Clinicians need to be aware of the risks this potential adverse drug reaction poses.

延伸閱讀